Oxcarbazepine Suspension
Product Images NDC 68094-123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68094-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxcarb 01)

FDA Label Image

Figure 1 (Oxcarb 02)

Figure 1 (Oxcarb 02)
This text provides results from a Tog-rank test, specifically the p-value which is 0.0001. There is also a table showing a time trial from Day 2 with the corresponding days from Day 1, as well as an observation in the Treatment Group relating to Oxcarbazeping.*
FDA Label Image

Figure 2 (Oxcarb 03)

Figure 2 (Oxcarb 03)
The text is a statistical analysis of the seizure rate between two groups, one that received oxcarbazepine treatment and another that received placebo. The log-rank test p-value was found to be 0.046, suggesting a statistically significant difference between the groups in terms of their seizure rates. The graph shows the number of days from the first dose to the first seizure, ranging from 0 to 140 days.*
FDA Label Image

Figure 3 (Oxcarb 04)

Figure 3 (Oxcarb 04)
This is a survival analysis result where a log-rank test was performed, resulting in a very low p-value of 0.0001. The graph shows the time to exit in days and indicates the treatment group (HIGH or LOW).*
FDA Label Image

Figure 4 (Oxcarb 05)

Figure 4 (Oxcarb 05)
This is a statistical analysis output showing the log-rank test results with a p-value of 0.0001. The remaining text is not readable and appears to be a combination of characters and symbols. Therefore, no additional useful information can be extracted from the text.*
FDA Label Image

Principal Display Panel (5 mL Cup Label)

Principal Display Panel (5 mL Cup Label)
This is a description of a prescription medication called PrecisionDose™ OXcarbazepine Oral Suspension. This medication comes in a bottle that delivers 5 mL of a solution containing 300 mg of the active ingredient, oxcarbazepine, which is used to treat seizures. The NDC (National Drug Code) for this medication is 68094-123-59. The manufacturer of the medication is Precision Dose, Inc. based in South Beloit, Illinois. The medication should be shaken well before use and stored at a temperature between 20°C and 25°C (68°F and 77°F). This medication is available by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.